Orthopedic Coding Alert

Knees:

Count Correctly to Keep Hyaluronic Acid Injections on Track

Timeframes, types of medications dictate your coding.Physicians administer hyaluronate or hyaluronic acid injections (commonly known by brand names Synvisc, Synvisc-One, Hyalgan, Supartz, and others) for osteoarthritis of the knee, but you need to look beyond a simple code when reporting the procedures.Code confusion: Hyaluronate injections have had its own J code for some time, "but it has been changed from 'unspecified' to its own assigned code, back to 'unspecified' and then back to an assigned HCPCS code," says Jacqui Jones, office manager for an orthopedic physician practice in Klamath Falls, Ore.Now that all hyaluronate injections fall under the same code, here are three checkpoints to keep in mind and help you calculate correctly.Verify the Type of MedicationPhysicians use hyaluronate injections to help alleviate the patient's pain due to osteoarthritis of the knee. The medications achieve the same purpose, and you report both types of injections with J7325 (Hyaluronan or derivative, [...]
You’ve reached your limit of free articles. Already a subscriber? Log in.
Not a subscriber? Subscribe today to continue reading this article. Plus, you’ll get:
  • Simple explanations of current healthcare regulations and payer programs
  • Real-world reporting scenarios solved by our expert coders
  • Industry news, such as MAC and RAC activities, the OIG Work Plan, and CERT reports
  • Instant access to every article ever published in Revenue Cycle Insider
  • 6 annual AAPC-approved CEUs
  • The latest updates for CPT®, ICD-10-CM, HCPCS Level II, NCCI edits, modifiers, compliance, technology, practice management, and more

Other Articles in this issue of

Orthopedic Coding Alert

View All